To hear about similar clinical trials, please enter your email below
Trial Title:
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
NCT ID:
NCT06067295
Condition:
Prostate Carcinoma
Conditions: Official terms:
Prostatic Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Non-Interventional Study
Description:
Non-interventional study
Arm group label:
Observational
Summary:
This study examines information from patients with prostate cancer that may have spread
from where it first started to nearby tissue, lymph nodes, or distant parts of the body
(advanced). By collecting biological samples (like blood, urine, and tissue), and health
information (such as treatment, diet, and quality of life) researchers hope to learn more
about prostate cancer and ways to improve outcomes in the future.
Detailed description:
PRIMARY OBJECTIVE:
I. To create an annotated biorepository with prospectively collected blood and urine
samples from men with advanced prostate cancer.
OUTLINE: This is an observational study.
Patients undergo blood and urine sample collection, complete surveys, and have their
medical records reviewed on study.
Criteria for eligibility:
Study pop:
Adult men diagnosed with advanced (metastatic) prostate cancer at Norris Comprehensive
Cancer Center and Los Angeles County hospital.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- * Men of all racial and ethnic groups 18 years of age or older
- Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled
to begin a new systemic treatment (including first or subsequent lines of
therapy)
- Prior participation on clinical trials is allowed
Exclusion Criteria:
- * Inability to give informed consent
Gender:
Male
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Los Angeles County-USC Medical Center
Address:
City:
Los Angeles
Zip:
90033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Cheryl Kefauver, RN
Phone:
323-865-0459
Email:
cheryl.kefauver@med.usc.edu
Investigator:
Last name:
Amir Goldkorn, MD
Email:
Principal Investigator
Facility:
Name:
USC / Norris Comprehensive Cancer Center
Address:
City:
Los Angeles
Zip:
90033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Cheryl Kefauver, RN
Phone:
323-865-0459
Email:
cheryl.kefauver@med.usc.edu
Investigator:
Last name:
Amir Goldkorn, MD
Email:
Principal Investigator
Start date:
February 21, 2023
Completion date:
February 21, 2027
Lead sponsor:
Agency:
University of Southern California
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
University of Southern California
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06067295
